Through a US$ 29 million grant, South Africa will receive enough medicine to provide HIV prevention to 450 000 people at high ...
The "miracle tool" HIV medicine lenacapavir will be sold in South Africa from as early as March or April 2026 according to gov.
South Africa has become the first African country, and our medicines regulator the third worldwide, to register the ...
Africanews on MSN
South Africa gives twice-yearly HIV prevention jab the green light
It is believed the lenacapavir shot could end HIV/Aids in the country within 14 to 18 years if enough people were to take it.
allAfrica.com on MSN
SA becomes first African country to register twice-a-year anti-HIV jab... at record speed
South Africa has become the first African country – and our medicines regulator the third worldwide – to register the ...
By William Baloyi When President Donald Trump issued an executive order suspending all foreign aid to South Africa, in ...
JOHANNESBURG (AP) — South Africa's health minister on Tuesday called lenacapavir, the first twice-yearly HIV prevention jab in the world, a “groundbreaking” tool to fight the disease, but warned ...
The drug, Lenacapavir, is the world's first injectable Pre-Exposure Prophylaxis (PrEP). According to the World Health ...
South Africa has become the first African country to register lenacapavir, a groundbreaking six-monthly HIV prevention ...
In South Africa’s richest area, mother-to-baby HIV transmission is a concern despite free prevention
PRETORIA, South Africa (AP) — It’s a worrying question for health officials in one of the richest and most developed areas of the African continent: Why are babies being born with HIV when free ...
HIV prevention drug Lenacapavir, which has been tested in South Africa during clinical trials, will be made available in the country in 2026 for high-risk groups.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results